• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    W

    Washington Adventist Hospital,Adventist HealthCare

    EST. 1907
    195论文总数
    8,430引用总数

    Divisions Adventist HealthCare White Oak Medical Center is a hospital with 180 private patient rooms and serves patients in Montgomery, Prince George's, and surrounding counties.Adventist HealthCare White Oak Medical Center operates as part of Adventist HealthCare, a health-care company that includes hospitals, home health agencies and other health care services. Adventist HealthCare is headquartered in Gaithersburg, Maryland.The hospital partners with the Food and Drug Administration, also located in White Oak, to collaborate on health research and medical innovation.Adventist HealthCare White Oak Medical Center will maintain robust medical and health services at its Takoma Park location including behavioral health services, a primary care clinic, physician offices, rehabilitation services and a Federally Qualified Health Center operated by Community Clinic, Inc.

    论文量&引用量时间轴

    机构学者

    论文(195)

    年份
    起
    –
    止
    排序
    1Global Results of Implantable Loop Recorder for Detection of Atrial Fibrillation after Stroke: Reveal LINQ Registry.
    Kazunori Toyoda,Kengo Kusano,Yasuyuki Iguchi,Takanori Ikeda,Itsuro Morishima,Hirofumi Tomita,Taku Asano,Teiichi Yamane,Ichiro Nakahara,Eiichi Watanabe,Junjiroh Koyama,Ritsushi Kato,

    Background We aimed to quantify the incidence of atrial fibrillation (AF) in patients with cryptogenic stroke globally, as well as separately in patients in and outside of Japan, using an implantable loop recorder from a prospective, observational, Reveal LINQ Registry. Methods and Results Patients developing cryptogenic stroke and monitored by implantable loop recorder for searching AF were studied. The primary end point was incidence of AF within 36 months after insertion. Secondary end points were recurrent ischemic stroke/transient ischemic attack and AF‐related treatment strategies. A total of 271 patients (61.6±14.3 years, 170 men, 60 from Japan) were enrolled from 12 countries. AF was detected in 28.2% at 36 months. The median time from enrollment to AF detection was 7.9 months. During the first 12 months, the AF detection rate slope was relatively steeper in the Japanese subgroup versus non‐Japanese patients. However, by 3 years, the cumulative incidence of AF detection did not differ between groups. Age was the only variable associated with AF detection (hazard ratio, 1.05 [95% CI, 1.02–1.07] per year), trending higher in older age groups. Of the 271 patients, 11 (4.1%) developed recurrent ischemic stroke/transient ischemic attack; AF was detected by implantable loop recorder in only 1 of these patients. Patients with detected AF were more commonly taking oral anticoagulation than those without AF at the last follow‐up (64.7% versus 25.3%, P<0.001). Conclusions The rate of AF detection was similar to other studies in stroke populations monitored by implantable loop recorders, including CRYSTAL‐AF (Cryptogenic Stroke and Underlying Atrial Fibrillation), STROKE‐AF (Stroke of Unknown Cause and Underlying Atrial Fibrillation) and PER‐DIEM (Post‐Embolic Rhythm Detection With Implantable Versus External Monitoring). Patients with detected AF more commonly initiated anticoagulation than those without AF.

    2024Journal of the American Heart Association(2024)引用:4
    引用
    AI阅读
    加入学术空间
    2Activated Clotting Time in Inpatient Diagnostic and Interventional Settings
    Dalton Heidi,Martin Michael,Garcia-Filion Pamela,Shavelle David,Huang Pei-Hsiu, Clark Justin,Beinart Sean, Israel Andrew,Korpi-Steiner Nichole

    Monitoring for the anticoagulant effect of unfractionated (UFH) at the point of care using activated clotting time in real time is vital where risk of thrombosis is high. Although monitoring UFH effect is a routine and important task, changing from one ACT instrument type or technology to another must be preceded by a clinical and statistical evaluation to determine the suitability and repeatability and establish normal and treatable ranges of this newer instrument. In this multi-center prospective evaluation we tested 1236 paired ACT+ samples, and 463 paired ACT-LR samples (1699 total) from enrolled study subjects. Clinical settings included CVOR cardiopulmonary bypass, at the beside in extracorporeal life support (ELS), the Cardiac Catheterization Lab (CCL) during diagnostic studies and percutaneous coronary interventions (PCI), interventional radiology procedures and EP interventions. This study found more consistent clinical performance from the GEM Hemochron 100 as compared to the current clinical model, the Hemochron Signature Elite. The bias of GEM Hemochron 100 for ACT+ and ACT-LR was greatest in the setting of the CVOR where ACT levels were high. ACT-LR measurements by the GEM Hemochron 100 were comparable to the SE when performed in settings of CCL, ECM, EP and ICU. Results obtained for both ACT-LR and ACT+ in all clinical settings in this study using the GEM Hemochron 100 are as accurate and more repeatable as those with the current clinically available Signature Elite.

    2022Journal of Thrombosis and Thrombolysis(2022)引用:4
    引用
    AI阅读
    加入学术空间
    3WA 0822-4203-4567 Alamat Toko Bunga Papan di Plaosan Magetan
    Alamat Florist
    2022Zenodo (CERN European Organization for Nuclear Research)(2022)
    引用
    AI阅读
    加入学术空间
    4Posterior Left Pericardiotomy for the Prevention of Atrial Fibrillation after Cardiac Surgery: an Adaptive, Single-Centre, Single-Blind, Randomised, Controlled Trial
    Mario Gaudino,Tommaso Sanna,Karla V Ballman,N Bryce Robinson,Irbaz Hameed,Katia Audisio,Mohamed Rahouma,Antonino Di Franco,Giovanni J Soletti,Christopher Lau,Lisa Q Rong,Massimo Massetti,

    BACKGROUND:Atrial fibrillation is the most common complication after cardiac surgery and is associated with extended in-hospital stay and increased adverse outcomes, including death and stroke. Pericardial effusion is common after cardiac surgery and can trigger atrial fibrillation. We tested the hypothesis that posterior left pericardiotomy, a surgical manoeuvre that drains the pericardial space into the left pleural cavity, might reduce the incidence of atrial fibrillation after cardiac surgery. METHODS:In this adaptive, randomised, controlled trial, we recruited adult patients (aged ≥18 years) undergoing elective interventions on the coronary arteries, aortic valve, or ascending aorta, or a combination of these, performed by members of the Department of Cardiothoracic Surgery from Weill Cornell Medicine at the New York Presbyterian Hospital in New York, NY, USA. Patients were eligible if they had no history of atrial fibrillation or other arrhythmias or contraindications to the experimental intervention. Eligible patients were randomly assigned (1:1), stratified by CHA2DS2-VASc score and using a mixed-block randomisation approach (block sizes of 4, 6, and 8), to posterior left pericardiotomy or no intervention. Patients and assessors were blinded to treatment assignment. Patients were followed up until 30 days after hospital discharge. The primary outcome was the incidence of atrial fibrillation during postoperative in-hospital stay, which was assessed in the intention-to-treat (ITT) population. Safety was assessed in the as-treated population. This study is registered with ClinicalTrials.gov, NCT02875405, and is now complete. FINDINGS:Between Sept 18, 2017, and Aug 2, 2021, 3601 patients were screened and 420 were included and randomly assigned to the posterior left pericardiotomy group (n=212) or the no intervention group (n=208; ITT population). The median age was 61·0 years (IQR 53·0-70·0), 102 (24%) patients were female, and 318 (76%) were male, with a median CHA2DS2-VASc score of 2·0 (IQR 1·0-3·0). The two groups were balanced with respect to clinical and surgical characteristics. No patients were lost to follow-up and data completeness was 100%. Three patients in the posterior left pericardiotomy group did not receive the intervention. In the ITT population, the incidence of postoperative atrial fibrillation was significantly lower in the posterior left pericardiotomy group than in the no intervention group (37 [17%] of 212 vs 66 [32%] of 208 [p=0·0007]; odds ratio adjusted for the stratification variable 0·44 [95% CI 0·27-0·70; p=0·0005]). Two (1%) of 209 patients in the posterior left pericardiotomy group and one (<1%) of 211 in the no intervention group died within 30 days after hospital discharge. The incidence of postoperative pericardial effusion was lower in the posterior left pericardiotomy group than in the no intervention group (26 [12%] of 209 vs 45 [21%] of 211; relative risk 0·58 [95% CI 0·37-0·91]). Postoperative major adverse events occurred in six (3%) patients in the posterior left pericardiotomy group and in four (2%) in the no intervention group. No posterior left pericardiotomy related complications were seen. INTERPRETATION:Posterior left pericardiotomy is highly effective in reducing the incidence of atrial fibrillation after surgery on the coronary arteries, aortic valve, or ascending aorta, or a combination of these without additional risk of postoperative complications. FUNDING:None.

    2021Lancet (London, England)(2021)引用:109
    引用
    AI阅读
    加入学术空间
    5Posterior Left Pericardiotomy Reduces Postoperative Atrial Fibrillation After Cardiac Surgery
    Mario F. Gaudino,Tommaso Sanna,John D. Puskas,Karla V. Ballman,Filippo Crea,A. Gillinov,Niv Ad,Pierre Voisine,J. Michael Dimaio,Joanna Chikwe,Stephen E. Fremes,Leonard N. Girardi
    2021CIRCULATION(2021)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 195 篇论文

    合作机构(100)

    波士顿科学合作论文 20
    哥伦比亚大学合作论文 20
    威廉·比蒙医院合作论文 13
    布莱根妇女医院合作论文 12
    杜克大学合作论文 12
    St Vincent''s Hospital,St Vincent''s Health合作论文 11
    University Hospitals Elyria Medical Center合作论文 10
    Sentara Virginia Beach General Hospital合作论文 7
    奥克兰市医院合作论文 7
    Oklahoma Heart Hospital合作论文 7

    机构统计